<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01879774</url>
  </required_header>
  <id_info>
    <org_study_id>002</org_study_id>
    <nct_id>NCT01879774</nct_id>
  </id_info>
  <brief_title>Characterisation of Neuropsychological and Motoric Performance in Patients With Hyponatremia</brief_title>
  <official_title>Characterisation of Neuropsychological and Motoric Performance in Patients With Hyponatremia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cologne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Cologne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this epidemiological study is to characterize the neuropsychological and motoric&#xD;
      performance in patients with hyponatremia. Newer studies revealed an association between mild&#xD;
      hyponatremia and unstable walking, frequency of falls and risk of a fracture, questioning the&#xD;
      paradigm of an &quot;asymptomatic&quot; hyponatremia. Until now, there is no known detailed&#xD;
      investigation and characterisation of the cognitive and motoric performance or limitation by&#xD;
      this disorder. Therefore this study will investigate patients with hyponatremia on the basis&#xD;
      of neuropsychological and neurological tests.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hyponatremia is the most common electrolyte disorder in outpatients and hospitalized&#xD;
      patients. The prevalence of hospital-associated hyponatremia is estimated to be up to 40%.&#xD;
      Especially mild to moderate hyponatremia (125-136 mmo/l) without apparent symptoms has&#xD;
      seldomly been accurately assessed but rather seen as clinically irrelevant. Cognitive&#xD;
      limitations, unstable gait and motoric disorders as well as depressive conditions were&#xD;
      described in smaller studies and single case reports.&#xD;
&#xD;
      In terms of the question, if a therapeutic influence is also reasonable in slight symptomatic&#xD;
      hyponatremia it is necessary to establish an accurate phenotyping of patients with&#xD;
      hyponatremia, which quantifies the individual cognitive, motoric and psychological qualities.&#xD;
&#xD;
      Patients with hyponatremia will be examined on the basis of standardized neuropsychological&#xD;
      and neurological tests. Following questions are to be answered with this study:&#xD;
&#xD;
        1. Which cognitive, motoric and psychological functions are impaired due to hyponatremia?&#xD;
&#xD;
        2. Is there a correlation between the extend of hyponatremia and the different test&#xD;
           results?&#xD;
&#xD;
        3. Is there an intraindividual difference in test results during hyponatremia and normal&#xD;
           sodium concentrations?&#xD;
&#xD;
      In addition to clinical testing, functional magnetic resonance imaging (fMRI) will be&#xD;
      performed before and after therapy in up to 40 patients with hyponatremia. Functional&#xD;
      magnetic resonance imaging (fMRI) is an imaging procedure in which local changes in cerebral&#xD;
      oxygen concentration can be used to draw conclusions about brain activity. In connection with&#xD;
      the current research project, an initial contribution is to be made in order to close the&#xD;
      existing knowledge gap as to whether a functionally-image-morphologically tangible change in&#xD;
      cerebral activity can also be depicted non-invasively by means of fMRI during hyponatremia or&#xD;
      after its compensation. Another component of cerebral evaluation in this context is volumetry&#xD;
      in fMRI.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 2012</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of Performance in individual tests</measure>
    <time_frame>Change in individual tests at Baseline and at least 48 hours after first assessment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of cerebral basal activity in fMRI during hyponatremia and after its compensation</measure>
    <time_frame>Change in fMRI from baseline and at least 48 hours after first assessment</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">190</enrollment>
  <condition>Hyponatremia</condition>
  <arm_group>
    <arm_group_label>Patients with hyponatremia</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Neuropsychological and motoric tests are conducted in patients with hyponatremia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with normal serum sodium</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Neuropsychological and motoric tests are conducted in patients with normal serum sodium.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Neuropsychological and motoric tests</intervention_name>
    <description>Neuropsychological tests&#xD;
Mini Mental Status Test&#xD;
Dem-Tect&#xD;
Rey-Osterrieth Complex Figure Test&#xD;
Trailmaking Test&#xD;
Beck Depression Inventory&#xD;
d2-R (optional)&#xD;
Motoric tests&#xD;
modified UPDRS (Unified Parkinson Disease Rating Scale) Part III&#xD;
Timed-up-and-go Test&#xD;
Halstead Fingertapping Test&#xD;
AIMS (Abnormal involuntary movement scale)&#xD;
EEG (only in patients with hyponatremia)&#xD;
MRI (only in patients with hyponatremia)</description>
    <arm_group_label>Patients with hyponatremia</arm_group_label>
    <arm_group_label>Patients with normal serum sodium</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Men and women 18 years of age or older&#xD;
&#xD;
          -  Hyponatremia with serum sodium &lt; 130 mmol/l&#xD;
&#xD;
          -  Men and women with normal serum sodium &gt; 130 mmol/l (control group)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  traumatic cerebral injury, hemorrhagic and ischemic insult as cause of hyponatremia&#xD;
&#xD;
          -  professional or private relationship between subject and the investigators, or&#xD;
             dependance on the investigators&#xD;
&#xD;
          -  Placement in an institution based on official orders&#xD;
&#xD;
          -  Patients who are unable to give informed consent&#xD;
&#xD;
          -  Patients with contraindication for MRI investigation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Volker Burst, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Cologne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Volker Burst, MD</last_name>
    <phone>+49 221 478 86285</phone>
    <email>volker.burst@uk-koeln.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cornelia Boehme</last_name>
    <email>cornelia.boehme@uk-koeln.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Cologne</name>
      <address>
        <city>Cologne</city>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dipartimento di Scienze Biomediche, Sperimentali e Cliniche Mario Serio</name>
      <address>
        <city>Firenze</city>
        <zip>50139</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alessandro Peri, Associate Professor</last_name>
    </contact>
    <investigator>
      <last_name>Alessandro Peri, Associate Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Clinico San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Italy</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 23, 2013</study_first_submitted>
  <study_first_submitted_qc>June 13, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 18, 2013</study_first_posted>
  <last_update_submitted>April 30, 2021</last_update_submitted>
  <last_update_submitted_qc>April 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Cologne</investigator_affiliation>
    <investigator_full_name>Volker Burst</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Hyponatremia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyponatremia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

